Curatis Holding AG (XSWX:CURN) Other Long Term Assets: CHF0.27 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:CURN Curatis Holding AG XSWX:CURN
33 GF Score
Price CHF20.80
! 7 Warning Signs
View Full Analysis

What is Curatis Holding AG Other Long Term Assets?

Curatis Holding AG XSWX:CURN +3.48% 33 Other Long Term Assets is CHF0.27 Mil as of Dec. 2025. GuruFocus rates XSWX:CURN with a GF Score™ of 33/100. The stock has 7 warning signs investors should review.

Curatis Holding AG's other long-term assets for the quarter that ended in Dec. 2025 was CHF0.27 Mil.

Curatis Holding AG's quarterly other long-term assets increased from Dec. 2024 (CHF0.25 Mil) to Jun. 2025 (CHF0.37 Mil) but then stayed the same from Jun. 2025 (CHF0.37 Mil) to Dec. 2025 (CHF0.27 Mil).

Curatis Holding AG's annual other long-term assets increased from Dec. 2023 (CHF0.00 Mil) to Dec. 2024 (CHF0.25 Mil) and increased from Dec. 2024 (CHF0.25 Mil) to Dec. 2025 (CHF0.27 Mil).

Curatis Holding AG Other Long Term Assets Historical Data

* Premium members only.

The historical data trend for Curatis Holding AG's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Curatis Holding AG Other Long Term Assets Chart

Curatis Holding AG Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Other Long Term Assets
0.00 -0.00 0.00 0.25 0.27

Curatis Holding AG Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.25 0.37 0.27
XSWX:CURN
33GF Score
Curatis Holding AG XSWX:CURN
Other Long Term Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Curatis Holding AG Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Frequently Asked Questions Learn more about Other Long Term Assets →
What does a Other Long Term Assets of CHF0.27 Mil mean?
Curatis Holding AG (XSWX:CURN) has a Other Long Term Assets of CHF0.27 Mil as of Dec. 2025. Other long-term assets as record on a company's balance sheet not categorized as standard assets. View historical data on Curatis Holding AG and its competitors.
Is Curatis Holding AG's Other Long Term Assets too high?
Curatis Holding AG's current Other Long Term Assets is CHF0.27 Mil. Overall, Curatis Holding AG has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Curatis Holding AG's Other Long Term Assets compare to ZTS and UTHR?
Curatis Holding AG's Other Long Term Assets of CHF0.27 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long Term Assets for a Drug Manufacturers company?
A good Other Long Term Assets depends on the Drug Manufacturers industry context. However, Other Long Term Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long Term Assets mean?
A high Other Long Term Assets can signal that a stock is expensive relative to its fundamentals. Other long-term assets as record on a company's balance sheet not categorized as standard assets. View historical data on Curatis Holding AG and its competitors. Curatis Holding AG's current Other Long Term Assets is CHF0.27 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Curatis Holding AG stock overvalued right now?
Curatis Holding AG (XSWX:CURN) has a current Other Long Term Assets of CHF0.27 Mil. The current Other Long Term Assets is CHF0.27 Mil. Curatis Holding AG's overall GF Score™ is 33/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long Term Assets calculated?
Other Long Term Assets is calculated from a company's financial statements. For Curatis Holding AG (XSWX:CURN), the current Other Long Term Assets is CHF0.27 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Curatis Holding AG Business Description

Other Exchanges CURNz:UK0QNS:UK26U:Germany
Address Weierweg 7, Liestal, CHE, CH-4410
Curatis Holding AG is a specialty pharmaceutical Company with two-pillar. On one hand, the Company trades and distributes specialty medicines in the rare disease and specialty medicines space i.e. acquires, licenses, distributes and promotes pharmaceutical products for the treatment and/or prevention of rare and specialty diseases in Switzerland. On the other hand, it is a drug development Company with a pipeline of product candidates, also predominantly in the orphan drug space.
33GF Score

Get the complete analysis for XSWX:CURN

Other Long Term Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF20.80
Price